G57321FI

Summary
GlyTouCan ID
G57321FI
IUPAC Condensed
GalNAc(a1-
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
The Human Metabolome Database
3D Structures
GLYCAM
DGalpNAca1-OH
GlycoShape
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying all 4 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
C1GALT1 (not applicable)
G57321FI
Ser/Thr
G00031MO
Ser/Thr
ST6GALNAC1 CMP-Neu5Ac
G57321FI
Ser/Thr
G36123IU
Ser/Thr
ST6GALNAC1 CMP-Neu5Ac
G57321FI
O-glycan Synthesis
G36123IU
O-glycan Synthesis
B3GNT6 UDP-GlcNAc
G57321FI
[alpha]-pNP
G00035MO
[alpha]-pNP
Displaying entries 6 - 9 of 9 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
C1GALT1 UDP-Gal
G57321FI
PSGL-1(EYEYLDYDFLPETEPPEM)
G00031MO
PSGL-1(EYEYLDYDFLPETEPPEM)
C1GALT1 UDP-Gal
G57321FI
O-glycan Synthesis
G00031MO
O-glycan Synthesis
B3GNT6 UDP-GlcNAc
G57321FI
O-glycan Synthesis
G00035MO
O-glycan Synthesis
B3GNT6 UDP-GlcNAc
G57321FI
[alpha]-pNP
G00035MO
[alpha]-pNP
Displaying entries 1 - 5 of 35 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Reference
ST6GALNAC3 CMP-Neu5Ac
G57321FI
Ser/Thr
ST6GAL2 CMP-Neu5Ac
G57321FI
para-nitrophenol
ST6GALNAC2 CMP-Neu5Ac
G57321FI
benzyl
ST6GALNAC1 CMP-Neu5Ac
G57321FI
[alpha]-Bz
ST6GALNAC2 CMP-Neu5Ac
G57321FI
Ser/Thr
GlycoEpitope
Epitope ID
EP0021
Pathway
Displaying entries 1 - 10 of 57 in total
Pathway Name Organism
E.coli O101 Escherichia coli
E.coli O103 Escherichia coli
E.coli O107 Escherichia coli
E.coli O112ab Escherichia coli
E.coli O112ac Escherichia coli
E.coli O116 Escherichia coli
E.coli O117 Escherichia coli
E.coli O125ab Escherichia coli
E.coli O127 Escherichia coli
E.coli O128ab-H27 Escherichia coli
Sequence Descriptors
GlycoCT
RES
1b:a-dgal-HEX-1:5
2s:n-acetyl
LIN
1:1d(2+1)2n
WURCS
WURCS=2.0/1,1,0/[a2112h-1a_1-5_2*NCC/3=O]/1/
Literature
Displaying entries 231 - 240 of 2052 in total
PubMed ID Title First Author Publication Date Source
30570431 Integrated Assessment of the Clinical Performance of GalNAc3-Conjugated 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides: I. Human Volunteer Experience Crooke ST 2019 Feb
  • PubChem
31891487 An N-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy Cheal SM 2019 Dec 31
  • PubChem
31792921 Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran de Paula Brandão PR 2019 Dec 02
  • PubChem
31491467 Structural basis of the pH-dependent conformational change of the N-terminal region of human mannose receptor/CD206 Hu Z 2019 Dec 01
  • PubChem
31373799 Engineering Orthogonal Polypeptide GalNAc-Transferase and UDP-Sugar Pairs Choi J 2019 Aug 02
  • PubChem
31374852 Galactosaminoglycans: Medical Applications and Drawbacks Pomin VH 2019 Aug 01
  • PubChem
31102718 Current and innovative emerging therapies for porphyrias with hepatic involvement Fontanellas A 2019 Aug
  • PubChem
30934149 N‐Acetyl‐<scp>d</scp>‐galactosamine prevents soya bean agglutinin‐induced intestinal barrier dysfunction in intestinal porcine epithelial cells Zhao B 2019 Apr
  • PubChem
30611426 The Preparation and Solution NMR Spectroscopy of Human Glycoproteins Is Accessible and Rewarding Barb AW 2019
  • PubChem
30204301 Multiplexed Metabolic Labeling of Glycoconjugates in Polarized Primary Cerebral Cortical Neurons Choi JY 2018 Sep 26
  • PubChem
PubAnnotation
Displaying entries 1 - 5 of 9 in total
Title Authors Source Publication Date PubMed ID
A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction.
  • Danussi C
  • Coslovi A
  • Campa C
  • Mucignat MT
  • Spessotto P
  • Uggeri F
  • Paoletti S
  • Colombatti A
Glycobiology 2009 Oct 19528665
Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.
  • Freire T
  • Lo-Man R
  • Piller F
  • Piller V
  • Leclerc C
  • Bay S
Glycobiology 2006 May 16449349
Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen.
  • Zhang Y
  • Iwasaki H
  • Wang H
  • Kudo T
  • Kalka TB
  • Hennet T
  • Kubota T
  • Cheng L
  • Inaba N
  • Gotoh M
  • Togayachi A
  • Guo J
  • Hisatomi H
  • Nakajima K
  • Nishihara S
  • Nakamura M
  • Marth JD
  • Narimatsu H
J Biol Chem 2003 Jan 3 12407114
Purification, characterization, and cDNA cloning of alpha-N-acetylgalactosamine-specific lectin from starfish, Asterina pectinifera.
  • Kakiuchi M
  • Okino N
  • Sueyoshi N
  • Ichinose S
  • Omori A
  • Kawabata S
  • Yamaguchi K
  • Ito M
Glycobiology 2002 Feb 11886841
Pursuit of optimal carbohydrate-based anticancer vaccines: preparation of a multiantigenic unimolecular glycopeptide containing the Tn, MBr1, and Lewis(y) antigens.
  • Allen JR
  • Harris CR
  • Danishefsky SJ
J Am Chem Soc 2001 Mar 7 11456809

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.2.1

Last updated: April 7, 2025